Patent details

Herbas

VPB

Print

EN | LT

LT - NASAL FORMULATION

EN - NASAL FORMULATION

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 31/55
		A61K 31/573
		A61K 9/00
		A61K 9/12
		A61M 11/04
		A61M 11/06
		A61M 15/00
		A61M 15/08
		A61P 27/14

European patent
(11)	Number of the document	2788001
(13)	Kind of document	T
(96)	European patent application number	12797884.9
	Date of filing the European patent application	2012-12-04
(97)	Date of publication of the European application	2014-10-15
(45)	Date of publication and mention of the grant of the patent	2015-12-02
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2012/074374
	Date	2012-12-04

PCT application publication
(87)	Number	WO 2013/083569
	Date	2013-06-13

Priority applications
(30)	Number	Date	Country code
	201161567893 P	2011-12-07	US
	201121812	2011-12-19	GB

Inventors
(72)	ZENG, Xian-Ming, US LY, Jade Ching-Ying, US DALVI, Mukul C, US

Grantee
(73)	Teva Branded Pharmaceutical Products R & D, Inc., 41 Moores Road, Frazer, Pennsylvania 19355, US

Title
(54)	NASAL FORMULATION
	NASAL FORMULATION